Review Article
What Is the Appropriate Acupuncture Treatment Schedule for Chronic Pain? Review and Analysis of Randomized Controlled Trials
Table 1
Characteristics of the included randomized controlled trials.
| Author | Year | Country | Clinical problem | Score | Sample Size (persons) | Scale | Duration of Each Treatment Session (mins) | Total Duration of Treatment (weeks) | Number of Treatment Sessions | Frequency (sessions/week) | DOSE (mins/week) | Real Treatment Pain Relief | Length of Follow-up 1 (week) | Real Follow-up Pain Relief | Length of Follow-up 2 (week) | Real Follow-up Pain Relief | Length of Follow-up 3 (week) | Real Follow-up Pain Relief |
| Lewis [30] | 2017 | Ireland | Shoulder pain | 5 | 227 | SPADI | 30 | 6 | 6 | 1.00 | 30 | -3.17 | 24 | 3.05 | 48 | 0.54 | | | Karatay [13] | 2017 | Turkey | Fibromyalgia | 5 | 75 | VAS | 30 | 4 | 8 | 2.00 | 60 | 29.74 | 4 | 38.50 | 12 | 36.04 | | | Ugurlu [12] | 2017 | Turkey | Fibromyalgia | 4 | 50 | VAS | 30 | 8 | 12 | 1.50 | 45 | 32.24 | (-) | | | | | | Naderinabi [26] | 2017 | Iran | Headache | 4 | 150 | VAS | unknown | 12 | 30 | 2.50 | unknown | 15.34 | (-) | | | | | | Garrido [31] | 2016 | Spain | Shoulder pain | 5 | 68 | VAS | 20 | 4 | 4 | 1.00 | 20 | 37.25 | 12 | 26.66 | | | | | Vas [21] | 2016 | Spain | Fibromyalgia | 5 | 164 | VAS | 20 | 9 | 9 | 1.00 | 20 | 16.33 | 15 | 8.37 | 39 | 17.68 | | | Hadianfard [29] | 2015 | Iran | Arm (Carpal Tunnel) | 3 | 50 | VAS | 20 | 4 | 8 | 2.00 | 40 | 11.48 | (-) | | | | | | Sahin [27] | 2015 | Turkey | Pelvis and hip | 4 | 100 | CPSI | 20 | 6 | 6 | 1.00 | 20 | 16.25 | 2 | 18.27 | 10 | 19.17 | 18 | 25.83 | MacPherson [23] | 2015 | UK | Neck Pain | 3 | 517 | NPQ | 50 | 12 | 12 | 1.00 | 50 | 15.15 | 12 | 13.62 | 36 | 9.73 | | | Aranha [18] | 2015 | Brazil | Myofascial pain | 4 | 60 | VAS | 30 | 4 | 8 | 2.00 | 60 | -1.63 | 4 | 3.71 | | | | | Hinman [22] | 2014 | Australia | Knee Pain | 4 | 282 | WOMAC | 20 | 12 | 9 | 0.75 | 15 | 5.07 | 36 | 11.10 | | | | | Itoh [34] | 2014 | Japan | Shoulder pain | 6 | 18 | VAS | 30 | 5 | 5 | 1.00 | 30 | 37.50 | 5 | 30.07 | 15 | 25.59 | | | Chen [35] | 2013 | USA | Knee OA | 6 | 214 | WOMAC | 20 | 9 | 12 | 1.33 | 27 | 56.78 | 14 | 63.57 | | | | | Tobbackx [28] | 2013 | Belgium | Neck (Whiplash) | 4 | 39 | VAS | 20 | 1 day | 1 | 1.00 | 20 | 10.82 | (-) | | | | | | Weiss [24] | 2013 | Germany | Low Back Pain | 3 | 143 | SF-36 | 35 | 3 | 6 | 2.00 | 70 | 5.58 | 12 | 9.59 | | | | | Sozen [16] | 2013 | Turkey | Headache | 3 | 56 | VAS | 20 | 5 | 20 | 4.00 | 80 | 20.65 | 12 | 18.48 | | | | | Hadianfard [19] | 2012 | Iran | Fibromyalgia | 4 | 30 | VAS | 30 | 2 | 6 | 3.00 | 90 | 37.50 | 2 | 6.25 | 6 | 0.00 | 46 | 12.50 | Itoh [36] | 2012 | Japan | Jaw | 6 | 16 | VAS | 30 | 5 | 5 | 1.00 | 30 | 45.92 | 5 | 50.65 | | | | | Miller [17] | 2011 | Israel | Knee OA | 3 | 55 | KSS | 20 | 8 | 16 | 2.00 | 40 | -4.36 | 4 | -25.27 | | | | | Molsberger [32] | 2010 | Germany | Shoulder pain | 5 | 424 | VAS | 20 | 6 | 15 | 2.50 | 50 | 15.21 | 12 | 21.26 | | | | | Cherkin [37] | 2009 | USA | Low Back Pain | 6 | 638 | SBS | 18 | 7 | 10 | 1.43 | 26 | -6.78 | 19 | -4.57 | 45 | -4.61 | | | Lathia [33] | 2009 | USA | Headache (tension) | 5 | 31 | SPADI | 30 | 6 | 12 | 2.00 | 60 | no baseline | (-) | | | | | | Inoue [25] | 2009 | Japan | Low Back Pain | 5 | 26 | VAS | 1 | 4 | 4 | 1.00 | 1 | 46.34 | 2 | 48.28 | 4 | 47.93 | | | Shen [20] | 2009 | Canada | Jaw | 3 | 28 | VAS | 15 | 1 day | 1 | 1.00 | 15 | 9.59 | (-) | | | | | |
|
|
(-): no follow-up; knee OA: knee osteoarthritis.
|